Delivery Order SPE2DB20D2104-SPE2DB22FR93W

Award Date 2/28/22
Potential Completion Date 3/1/22
Potential Value $1.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,131.69 firm-fixed-price delivery order is for the supply of 500 units of Sertraline HCL 100 mg tablets, a medication commonly used to treat mental health conditions. The contract has an ultimate completion date of November 20, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,085.40 Firm Fixed Price delivery order is for the supply of 4,566,281,415 units of 100 mg Sertraline HCL tablets. The contract has an ultimate completion date of October 31, 2024 and was awarded on October 30, 2024. There was no set-aside designation used for this open competition contract. Amerisourcebergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,482.24 Firm Fixed Price delivery order is for the supply of 4,561,904,841 units of Sertraline Hydrochloride 100 mg tablets. The contract has an ultimate completion date of August 23, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,390.68 firm fixed-price delivery order contract is to supply 4,557,963,840 units of the medication Sertraline HCL 100 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,124.64 firm fixed-price delivery order is for the supply of Sertraline HCL 100 mg tablets. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has extensive experience in pharmaceutical distribution and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The contract, valued at $1,008.25, is for the delivery of Sertraline HCL 100 mg tablets. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Cencora,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,230.48 firm fixed-price delivery order is for the supply of 100-count units of 50 mg sertraline hydrochloride tablets, a common antidepressant medication. The contract has a ceiling value of $1,230.48 and an ultimate completion date of March 20, 2024. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,126.04 firm fixed-price delivery order is for the procurement of 500 units of the medication Sertraline HCL 100 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award, valued at $1,931.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Sertraline HCL 50 mg tablets. The contract has an ultimate completion date of May 24, 2023. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00,...
This federal contract award is for Sertraline HCL 100 mg tablets, a generic pharmaceutical product, valued at $1,863.60. The award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 21, 2022. This contract is a delivery order with a firm fixed price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which serves as a critical...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB22FR93W
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,124.64 firm fixed-price delivery order is for the supply of 4,556,391,802 units of Sertraline HCL 100 mg tablets. The contract has no set-aside designation, indicating open competition.

The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen has also secured a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 2/27/25, 10:26 AM